Dr. Carol Prives
DaCosta Professor of Biology in the Department of Biological Sciences at Columbia University, USA
Dr. Prives is known as a leader in the p53 tumor suppressor field in cancer research. Her laboratory discovered that p53 is a sequence-specific transcriptional activator and that cancer-related mutants of p53 are defective in this function. She was also among the first to elucidate how p53 is stabilized after DNA damage. In 1998 she was awarded a Research Professorship from the American Cancer Society. In 2000 she was elected to the American Academy of Arts and Sciences and in 2005 to the Institute of Medicine. In 2008, Prives was elected as member of the prestigious National Academy of Sciences (NAS) for her excellence in original scientific research. She has served on numerous editorial boards as well as on a number of scientific advisory boards, including chairing two NIH Study Sections, the Board of Scientific Directors of the National Cancer Institute, the Damon Runyon Fellowship Committee, New Jersey Cancer Commission, and the Howard Hughes Medical Institute. She also served on the American Association for Cancer Research Board of Directors (2004-2007).